106 related articles for article (PubMed ID: 2905665)
41. Competitive and non-competitive NMDA antagonists limit dynorphin A-induced rat hindlimb paralysis.
Bakshi R; Faden AI
Brain Res; 1990 Jan; 507(1):1-5. PubMed ID: 1967971
[TBL] [Abstract][Full Text] [Related]
42. Pharmacological characterization of the opioid receptor in the submucous plexus of the guinea-pig oesophagus.
Kamikawa Y; Shimo Y
Br J Pharmacol; 1983 Apr; 78(4):693-9. PubMed ID: 6303485
[TBL] [Abstract][Full Text] [Related]
43. Proenkephalin B (prodynorphin)-derived opioid peptides: evidence for a differential processing in lobes of the pituitary.
Seizinger BR; Höllt V; Herz A
Endocrinology; 1984 Aug; 115(2):662-71. PubMed ID: 6146512
[TBL] [Abstract][Full Text] [Related]
44. Dynorphin A and related peptides administered intrathecally in the rat: a search for putative kappa opiate receptor activity.
Stevens CW; Yaksh TL
J Pharmacol Exp Ther; 1986 Sep; 238(3):833-8. PubMed ID: 2875172
[TBL] [Abstract][Full Text] [Related]
45. Dynorphin A (1-13) potentiates dynorphin A (1-17) on loss of the tail-flick reflex after intrathecal injection in the rat.
Qu ZX; Isaac L
Brain Res; 1993 May; 610(2):340-3. PubMed ID: 8100473
[TBL] [Abstract][Full Text] [Related]
46. Structure-activity analysis of dynorphin A toxicity in spinal cord neurons: intrinsic neurotoxicity of dynorphin A and its carboxyl-terminal, nonopioid metabolites.
Hauser KF; Knapp PE; Turbek CS
Exp Neurol; 2001 Mar; 168(1):78-87. PubMed ID: 11170722
[TBL] [Abstract][Full Text] [Related]
47. TRH fails to antagonize the acute paralytic effects of intrathecal dynorphin A and substance P antagonists in the rat.
Martinez-Arizala A; Long JB; Holaday JW
Brain Res; 1988 Nov; 473(2):385-8. PubMed ID: 2466528
[TBL] [Abstract][Full Text] [Related]
48. Direct pituitary stimulation of thyrotropin secretion by opioid peptides.
Judd AM; Hedge GA
Endocrinology; 1983 Aug; 113(2):706-10. PubMed ID: 6872946
[TBL] [Abstract][Full Text] [Related]
49. Dynorphin and neoendorphin peptides decrease dorsal root ganglion neuron calcium-dependent action potential duration.
Werz MA; Macdonald RL
J Pharmacol Exp Ther; 1985 Jul; 234(1):49-56. PubMed ID: 2409273
[TBL] [Abstract][Full Text] [Related]
50. Immunohistochemical distribution of dynorphin B in rat brain: relation to dynorphin A and alpha-neo-endorphin systems.
Weber E; Barchas JD
Proc Natl Acad Sci U S A; 1983 Feb; 80(4):1125-9. PubMed ID: 6133279
[TBL] [Abstract][Full Text] [Related]
51. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
[TBL] [Abstract][Full Text] [Related]
52. Intrathecal morphine-3-glucuronide-induced nociceptive behavior via Delta-2 opioid receptors in the spinal cord.
Komatsu T; Katsuyama S; Nagase H; Mizoguchi H; Sakurada C; Tsuzuki M; Sakurada S; Sakurada T
Pharmacol Biochem Behav; 2016 Jan; 140():68-74. PubMed ID: 26476133
[TBL] [Abstract][Full Text] [Related]
53. Possible involvement of dynorphin A release via mu1-opioid receptor on supraspinal antinociception of endomorphin-2.
Sakurada S; Sawai T; Mizoguchi H; Watanabe H; Watanabe C; Yonezawa A; Morimoto M; Sato T; Komatsu T; Sakurada T
Peptides; 2008 Sep; 29(9):1554-60. PubMed ID: 18571771
[TBL] [Abstract][Full Text] [Related]
54. Contribution of spinal mu(1)-opioid receptors and dynorphin B to the antinociception induced by Tyr-d-Arg-Phe-Sar.
Mizoguchi H; Ito K; Watanabe H; Watanabe C; Katsuyama S; Fujimura T; Sakurada T; Sakurada S
Peptides; 2006 Nov; 27(11):2786-93. PubMed ID: 16919848
[TBL] [Abstract][Full Text] [Related]
55. [3H]dynorphin A binding and kappa selectivity of prodynorphin peptides in rat, guinea-pig and monkey brain.
Young EA; Walker JM; Lewis ME; Houghten RA; Woods JH; Akil H
Eur J Pharmacol; 1986 Mar; 121(3):355-65. PubMed ID: 2870933
[TBL] [Abstract][Full Text] [Related]
56. Evolution of gnathostome prodynorphin and proenkephalin: characterization of a shark proenkephalin and prodynorphin cDNAs.
Komorowski LK; Lecaude SG; Westring CG; Danielson PB; Dores RM
Gen Comp Endocrinol; 2012 Jul; 177(3):353-64. PubMed ID: 22210245
[TBL] [Abstract][Full Text] [Related]
57. D-Ala2,F5Phe4-dynorphin amide, an opiate with analgesic and toxic properties.
Kostrzewa RM; Brus R; Coy DH; Criswell H; Coogan PS; Kastin AJ
Pol J Pharmacol Pharm; 1992; 44(2):109-20. PubMed ID: 1357636
[TBL] [Abstract][Full Text] [Related]
58. In vitro-perifused rat testes secrete beta-endorphin and dynorphin: their effect on testosterone secretion.
Margioris AN; Koukoulis G; Grino M; Chrousos GP
Biol Reprod; 1989 Apr; 40(4):776-84. PubMed ID: 2568857
[TBL] [Abstract][Full Text] [Related]
59. Effects of high intravenous doses of dynorphin A(1-13) on tail flick latency and central nervous system histology in rats.
Pentel PR; Wananukul W; Hooke LP; Jones CR; Hatsukami D; Anderson WR; Lee NM
Pharmacol Biochem Behav; 1995; 51(2-3):387-90. PubMed ID: 7667358
[TBL] [Abstract][Full Text] [Related]
60. Spinal involvement of both dynorphin A and Met-enkephalin in the antinociception induced by intracerebroventricularly administered bremazocine but not morphine in the mouse.
Tseng LF; Collins KA
J Pharmacol Exp Ther; 1993 Sep; 266(3):1430-8. PubMed ID: 8103794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
